Healthy Volunteers Clinical Trial
— SLS-JUMPOfficial title:
The Effect of Gravity on the Muscular Control of Landing From a Jump
NCT number | NCT02563223 |
Other study ID # | 11-118 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | July 23, 2015 |
Last updated | September 28, 2015 |
Start date | November 2011 |
In this project, investigators propose to study the jump in different reduced gravity fields
obtained during parabolic flights profiles but also during increased gravity fields obtained
during turns of the airplane or during the pull-up phase of the parabola. By means of a
pneumatic device, an additional pull-down force will be added to the vertical force caused
by the gravity field. By combining different levels of gravity to different levels of the
added pull-down force it will be possible to dissociate the respective contribution of the
otolithic and proprioceptive systems to the anticipatory landing response. To the
investigators' knowledge, only one study has modified the gravity field during a jump.
However, these authors did not add a pull-down force and only analyzed the vertical ground
reaction force.
A better knowledge of the sensory-motor control of the landing phase of a jump will also
increase the investigators' understanding of the physiopathology of joint instability.
Indeed, similarities could be found between the evolution of the motor response due to the
absence gravity during long-duration space flights and the pathological process of chronic
ankle and knee instability. The knowledge generated by this study will thus provide
invaluable information in the context of human performance and rehabilitation.
Status | Recruiting |
Enrollment | 18 |
Est. completion date | |
Est. primary completion date | October 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Healthy volunteers (men or women) - Aged from 18 to 65 - Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC) - Who accepted to take part in the study - Who have given their written stated consent - Who has passed a medical examination similar to a standard aviation medical examination for private pilot aptitude. There will be no additional test performed for subject selection Exclusion Criteria: - Person who took part in a previous biomedical research protocol, of which exclusion period is not terminated - Pregnant women - Person with medical history of musculoskeletal disorders of the lower limbs, pelvis or spine, neurological or vestibular disorders. |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
France | Umr Ucbn/Inserm U1075 Comete | Caen CEDEX | Basse-Normandie |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Caen |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Electromyography (Amplitude - mV and latency - ms) | EMG (electrical activity produced my muscles when they contract) will be recorded with a MyoSystem 1400L using surface electrodes at the level of the lateral gastrocnemius, medial gastrocnemius, tibialis anterior and peroneus longus, and on the thigh at the level of the vastus lateralis, vastus medialis and lateral hamstrings and medial hamstrings. EMG activation (amplitude and latency) will be measured during jumps at different level of gravity and pull-down forces. |
baseline | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |